Parallel large eddy simulations of wind farms with the actuator line method

Parallel Computation of wind farm Large Eddy Simulations (LES) requires the use of with Wind Turbine Models (WTM). CFD and WTM demand different domain decompositions as optimal CFD and WTM decompositions do not necessarily coincide. Nevertheless, data exchange between CFD and WTM must not penalize overall simulation performance. A coupling strategy for data exchange is described and has been tested. It enables the parallel simulation of wind farms with WTM. Simulations of wind turbine wakes have been achieved. Preliminary results show the parallelization works properly but that the simulations do not resolve flows with enough accuracy.Peer ReviewedPostprint (published version

Faunal study from Abrigo de la Quebrada level IV and its contribution to the knowledge of the economy and human behaviour in the Middle Palaeolithic of iberian mediterranean region

El Abrigo de la Quebrada (Chelva, Valencia) es un yacimiento con varios niveles de ocupación del Paleolítico medio. El nivel IV, con dos dataciones de 43.930 ± 750 BP (Beta-244002) y >51,6 ka BP (OxA-24855), se caracteriza por su estructura de palimpsesto y la elevada densidad de restos arqueológicos (industria lítica, fauna, carbones y estructuras de combustión). El conjunto óseo se compone de 100.907 restos, con una mayor presencia de las familias Bovidae, Equidae, Cervidae y Testudinidae. La presencia de fracturas frescas, muescas de percusión y marcas de corte confirma el carácter antrópico de la muestra, así como las termoalteraciones. Dada la elevada fragmentación de la muestra (1% de identificados), se ha llevado a cabo también el análisis de las esquirlas óseas de <3cm, las cuales han reafirmado los datos del estudio arqueozoológico y tafonómico de los restos identificados. El trabajo aporta nuevos datos económicos en el marco del Paleolítico medio de la zona mediterránea de la Península ibérica.The site of Abrigo de la Quebrada (Chelva, Valencia) is a shelter with several levels with Middle Palaeolithic occupations. The level IV, with two dates of 43,930 ± 750 BP (Beta-244002) and >51.6 ka BP (OxA-24855), has a palimpsest structure and a high density of archaeological remains (lithic industry, fauna, charcoals and combustion structures). The bone sample contains 100,907 remains, with a better representation of Bovidae, Equidae, Cervidae and Testudinidae families. The presence of fresh fractures, percussion notches and cut marks confirms the anthropogenic character of the sample, as well as the thermoalterations. Given the high fragmentation of the bones (1% of identified), a specific analysis of the bone chips (less than <3cm) has been carried out. The results have confirmed the data obtain from the archaeozoological and taphonomical study of the identifiable remains. The current work contributes with new economic data to the Middle Palaeolithic framework of the Iberian Mediterranean region.Ministerio de Ciencia e Innovación HAR2011-24978 HAR2014-52671-P HAR-2017-85153-PGeneralitat Valenciana PROMETEOII/ 2013/016 PROMETEO/2017/06

Evolución de la mortalidad por cáncer de mama y diseminación de la mamografía de cribado en Cataluña: un análisis por regiones sanitarias

Fundamento: El descenso de las tasas de mortalidad por cáncer de mama (CM) se ha atribuido a la implantación de programas de cribado y a avances terapéuticos. El objetivo de este trabajo es comparar la evolución de su mortalidad en las regiones sanitarias de Cataluña en el periodo 1993-2007. Paralelamente, se ha analizado la diseminación de la mamografía periódica en las regiones sanitarias. Métodos: Se analizaron los datos del registro de mortalidad y encuestas de salud. Se utilizaron regresiones de Poisson y «joinpoint» para comparar las tasas de mortalidad por CM y analizar su evolución temporal. Se utilizaron modelos de efectos mixtos para comparar el nivel y la evolución de la mortalidad por regiones. Resultados. La tasa de mortalidad por CM descendió un 3% anual en Cataluña. Entre 1993 y 2007, la tasa estandarizada varió de 34,8 a 23,3 por 100.000 mujeres. Barcelona ciutat presentó unas tasas de mortalidad más elevadas que las regiones Centre (ratio de tasas (RT)=0,87), Costa de Ponent (RT=0,89), Tarragona (RT=0,9) y Lleida (RT=0,915), pero estas diferencias tendieron a desaparecer. No se observaron cambios de tendencia en la evolución de la mortalidad de las regiones, excepto en la región Centre. Durante los años 1990 Barcelona ciutat presentó unos porcentajes de utilización de mamografía periódica del 36,1% de las mujeres de 40-74 años, en la encuesta de 1994, la región Centre (23,7%) y Costa de Ponent (25,2%). Conclusiones: La progresiva utilización de mamografía periódica y la disminución de la mortalidad por CM fueron similares en las regiones sanitarias de Cataluña.Background: The decrease of breast cancer (BC) mortality rates has been attributed to early detection programs and therapeutic advances. The objective is to compare BC mortality trend in health regions of Catalonia during the period 1993-2007. In parallel, dissemination of periodic mammography in the health regions has been analyzed. Methods: Mortality and health surveys data were used. Poisson and «joinpoint» regression analyses were used to compare regional BC mortality rates and quantify their temporal evolution. Mixed effects models were used to compare the rates and their evolution by region. Results: The BC mortality rate decreased 3% annually in Cataluña. Between 1993 and 2007, the standard mortality rate changed from 34.8 to 23.3 per 100,000 women. Barcelona ciutat showed higher mortality rates than the Centre (rate ratio (RR)=0.873), Costa de Ponent (RR=0.885), Tarragona (RR=0.9) and Lleida regions (RR=0.915), but these differences tend to disappear over time. There were no observed trend changes in the evolution of the regional mortality rates, except in the Centre region. The use of periodic mammography was similar across health regions. During the 90s, Barcelona ciutat had a 36.1% utilization of periodic mammography in women aged 40-74, in the 1994 survey, the Centre 23.7 and Costa de Ponent 25.2%. Conclusions: The progressive increase in the use of periodic mammography and the decrease of BC mortality were similar in the eight health regions of Catalonia

Mediterranean diet supplemented with nuts reduces waist circumference and shifts lipoprotein subfractions to a less atherogenic pattern in subjects at high cardiovascular risk

[Objective]: The PREDIMED trial showed that Mediterranean diets supplemented with either extra-virgin olive oil or nuts reduced incident cardiovascular events compared to a control diet. Consumption of both supplemental foods has been associated with reduced LDL-cholesterol, but it is unknown whether they can shift lipoprotein subfractions to a less atherogenic pattern. We investigated changes in adiposity and lipoprotein subfractions after consumption of the PREDIMED diets.[Methods]: In a PREDIMED sub-cohort (n = 169), lipoprotein subclasses (particle concentrations and size) were determined by nuclear magnetic resonance spectroscopy at baseline and after intervention for 1 year.[Results]: Participants allocated to the Mediterranean diet supplemented with nuts showed significant reductions from baseline of waist circumference (mean [95% CI]; −5 cm [−7; −3]) and concentrations of medium-small (−27 nmol/l [−46; −8]) and very small LDL (−111 nmol/l [−180; −42]); decreased LDL particle number (a nuclear magnetic resonance-specific measurement) (−98 nmol/l [−184; −11]); and an increase of large LDL concentrations (54 nmol/l [18; 90]), with a net increase (0.2 nmol/l [0.1; 0.4]) of LDL size. The Mediterranean diets with olive oil and nuts increased large HDL concentrations (0.6 μM [0.0; 1.1] and 1.0 μM [0.4; 1.5], respectively). Compared to the other two intervention groups, participants in the nut-enriched diet showed significantly reduced waist circumference (p ≤ 0.006, both) and increased LDL size (p < 0.05, both).[Conclusion]: Lipoprotein subfractions are shifted to a less atherogenic pattern by consumption of Mediterranean diets enriched with nuts. The results contribute mechanistic evidence for the reduction of cardiovascular events observed in the PREDIMED trial.This study was funded in part by ISCIII (Spanish Ministry of Economy) through grants RTIC G03/140, RTIC RD 06/0045, and FIS PS09/01292 and grant CNIC 06/2007 from Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain. AS-V was supported by post-doctoral contract FIS CD07/0083. MF was supported by a joint contract of ISCIII and the Health Department of the Catalan Government (Generalitat de Catalunya), CP 06/00100

Laparoscopic vs. open surgery for the treatment of iatrogenic colonoscopic perforations: a systematic review and meta-analysis

Quality assessment of the included non-randomized studies based on the Newcastle-Ottawa Scale (NOS). (DOCX 57 kb

New data for the Middle Paleolithic at the Vinalopó Mid Basin: the spot Paraje Natural Municipal de Los Aljezares (Aspe, Alicante). Techno-typological analysis of surface lithic industry

Se estudian los materiales líticos en superficie procedentes del Paraje Natural de Los Aljezares. El objetivo es dar a conocer el yacimiento y valorar su interés en el contexto regional. Los datos obtenidos permiten establecer la presencia de materiales adscritos al Paleolítico medio y superior. Este enclave aporta nueva información al poblamiento de la cuenca media del Vinalopó y proporciona un marco de comparación con otros conjuntos ubicados en las inmediaciones de la misma.S’estudien els materials lítics en superfície procedents del Paraje Natural de Los Aljezares. L’objectiu és donar a conèixer el jaciment i valorar el seu interès en el context regional. Les dades obtingudes permeten establir la presència de materials adscrits al Paleolític mitjà i superior. Aquest enclavament aporta nova información al poblament de la conca mitjana del Vinalopó i proporciona un marc de comparació amb altres conjunts situats en els voltants d’aquesta.In this paper surface lithic materials from The Paraje Natural de Los Aljezares are studied. The aim is to raise awareness of the site and assess its interest in the regional context. The data obtained allow us to establish the presence of materials assigned to the Middle and Upper Paleolithic. This site provides new information to the settlement of the Vinalopó middle basin and provides a framework for comparison with other sites located in the vicinity.La investigación se ha financiado a través de los siguientes proyectos de investigación: “Estudio del registro climático reciente preservado en depósitos cuaternarios: el caso de Los Aljezares (Aspe, Alicante) y su relación con los depósitos del Medio y Bajo Vinalopó” (GRE17-02), “El pasado lejano: aproximación a la conducta y la ocupación del territorio en el paleolítico valenciano” (PROMETEO/2017/060) y “Síntesis del Paleolitico medio y superior en Valencia y Murcia: aspectos cronológicos, paleoambientales, económicos y culturales” (HAR2017-85153-P)

Oral metronomic vinorelbine combined with endocrine therapy in hormone receptor-positive HER2-negative breast cancer: SOLTI-1501 VENTANA window of opportunity trial

Background: The biological effect of oral metronomic vinorelbine (mVNB) alone or in combination with endocrine therapy in patients with hormone receptor-positive (HR+)/HER2-negative breast cancer has been scarcely addressed. Methods: Postmenopausal women with untreated stage I-III HR+/HER2-negative breast cancer were randomized (1:1:1) to receive 3 weeks of letrozole (LTZ) 2.5 mg/day, oral mVNB 50 mg 3 days/week, or the combination. The primary objective was to evaluate, within PAM50 Luminal A/B disease, if the anti-proliferative effect of LTZ+mVNB was superior to monotherapy. An anti-proliferative effect was defined as the mean relative decrease of the PAM50 11-gene proliferation score in combination arm vs. both monotherapy arms. Secondary objectives included the evaluation of a comprehensive panel of breast cancer-related genes and safety. An unplanned analysis of stromal tumor-infiltrating lymphocytes (sTILs) was also performed. PAM50 analyses were performed using the nCounter®-based Breast Cancer 360 gene panel, which includes 752 genes and 32 signatures. Results: Sixty-one patients were randomized, and 54 paired samples (89%) were analyzed. The main patient characteristics were mean age of 67, mean tumor size of 1.7 cm, mean Ki67 of 14.3%, stage I (55.7%), and grades 1-2 (90%). Most baseline samples were PAM50 Luminal A (74.1%) or B (22.2%). The anti-proliferative effect of 3 weeks of LTZ+mVNB (- 73.2%) was superior to both monotherapy arms combined (- 49.9%; p = 0.001) and mVNB (- 19.1%; p < 0.001). The anti-proliferative effect of LTZ+mVNB (- 73.2%) was numerically higher compared to LTZ (- 65.7%) but did not reach statistical significance (p = 0.328). LTZ+mVNB induced high expression of immune-related genes and gene signatures, including CD8 T cell signature and PDL1 gene and low expression of ER-regulated genes (e.g., progesterone receptor) and cell cycle-related and DNA repair genes. In tumors with ≤ 10% sTILs at baseline, a statistically significant increase in sTILs was observed following LTZ (paired analysis p = 0.049) and LTZ+mVNB (p = 0.012). Grade 3 adverse events occurred in 3.4% of the cases. Conclusions: Short-term mVNB is well-tolerated and presents anti-proliferative activity alone and in combination with LTZ. The high expression of immune-related biological processes and sTILs observed with the combination opens the possibility of studying this combination with immunotherapy. Further investigation comparing these biological results with other metronomic schedules or drug combinations is warranted

Intrinsic Subtypes and Gene Expression Profiles in Primary and Metastatic Breast Cancer

Biological changes that occur during metastatic progression of breast cancer are still incompletely characterized. In this study, we compared intrinsic molecular subtypes and gene expression in 123 paired primary and metastatic tissues from breast cancer patients. Intrinsic subtype was identified using a PAM50 classifier and χ 2 tests determined the differences in variable distribution. The rate of subtype conversion was 0% in basal-like tumors, 23.1% in HER2-enriched (HER2-E) tumors, 30.0% in luminal B tumors, and 55.3% in luminal A tumors. In 40.2% of cases, luminal A tumors converted to luminal B tumors, whereas in 14.3% of cases luminal A and B tumors converted to HER2-E tumors. We identified 47 genes that were expressed differentially in metastatic versus primary disease. Metastatic tumors were enriched for proliferation-related and migration-related genes and diminished for luminal-related genes. Expression of proliferation-related genes were better at predicting overall survival in metastatic disease (OSmet) when analyzed in metastatic tissue rather than primary tissue. In contrast, a basal-like gene expression signature was better at predicting OSmet in primary disease compared with metastatic tissue. We observed correlations between time to tumor relapse and the magnitude of changes of proliferation, luminal B, or HER2-E signatures in metastatic versus primary disease. Although the intrinsic subtype was largely maintained during metastatic progression, luminal/HER2-negative tumors acquired a luminal B or HER2-E profile during metastatic progression, likely reflecting tumor evolution or acquisition of estrogen independence. Overall, our analysis revealed the value of stratifying gene expression by both cancer subtype and tissue type, providing clinicians more refined tools to evaluate prognosis and treatment. Cancer Res; 77(9); 1-9. ©2017 AACR

Higher versus lower nut consumption and changes in cognitive performance over two years in a population at risk of cognitive decline: a cohort study

Background: Tree nuts and peanuts (henceforth, nuts) are nutrient-dense foods rich in neuroprotective components; thus, their consumption could benefit cognitive health. However, evidence to date is limited and inconsistent regarding the potential benefits of nuts for cognitive function. Objective: To prospectively evaluate the association between nut consumption and 2-y changes in cognitive performance in older adults at cognitive decline risk. Methods: A total of 6,630 participants aged 55 to 75 y (mean age 65.0±4.9 y, 48.4% women) with overweight/obesity and metabolic syndrome completed a validated semi-quantitative food frequency questionnaire and a comprehensive battery of neuropsychological tests at baseline and a 2-y follow-up. Composite cognitive scores were used to assess global, general, attention, and executive function domains. Nut consumption was categorized as Results: Nut consumption was positively associated with 2-y changes in general cognitive function (P-trend Conclusion: Frequent nut consumption was associated with a smaller decline in general cognitive performance over 2 y in older adults at risk of cognitive decline. Randomized clinical trials to verify our findings are warranted